ReviewInternational journal of hematology2023

Prophylactic or preemptive tyrosine kinase inhibitor therapy after allogeneic hematopoietic cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.

Hideki NakasonePubMed ↗Publisher ↗

No numbers read from the abstract.